Despite his tax woes, Shkreli is offering $10 million to Kanye West for sole possession of the singer's new album.» Read More
Many returning Obamacare customers will be able to find plans costing them less than $100, or even $75 per month.
The Cleveland Clinic will work to verify technology devised by diagnostic start-up Theranos.
Pressure from insurance company negotiations and higher drug costs are forcing hospitals to become more efficient, health-care chiefs said.
Valeant said it is terminating all ties with Philidor due to allegations relating to the specialty pharmacy distributor's business practices.
Data from Sikka Software show that dentists are the biggest winners during the Halloween season, because of so many cracked teeth from hard candy.
Health and nutrition guidelines should "cease recommending low-fat diets for weight loss," says a new meta-analysis from Harvard.
The field of gene testing is verging on a "huge breakthrough," Cleveland Clinic CEO Toby Cosgrove told CNBC.
The number of preferred provider organization health plans will fall sharply, by more than 40 percent.
Employment-related stress can cut the number of years people live, according to a study discussed in Washington Post's Wonkblog.
Are we about to lose our appetite for hot dogs, bacon, and pies?
Health-care expenses in retirement are climbing. Sharon Epperson shares tips on how to plan to make sure you're covered.
A possible deal between Ireland-based Allergan and U.S. drugmaker Pfizer raises questions about another pharmaceutical tax inversion.
The Chinese Communist Party's decision to do away with the one-child policy will benefit companies that sell baby products market in the country.
Pfizer has held early talks with Allergan to discuss what could be the biggest takeover deal this year, according to media reports.
Existing Obamacare customers who switched plans for 2015 saved an average of almost $400 per year in premiums.
Here's what should be done to provide Americans with care that's both affordable and high quality, says Steve Odland.
Biotech unicorn Theranos is under fire again.
Ken Frazier discussed drug pricing with the president, and he believes many in Washington have a "rational" view of the situation.
Valeant Pharmaceuticals said it has formed a committee to review allegations against the company.
Valeant held a conference call Monday morning to defend itself from recent allegations. Here is what Wall Street said after the call.
Get the best of CNBC in your inbox